Life sciences and biotech UK bets £500 million on homegrown AI: drug discovery and defence tech among first to win backing The UK government has launched a landmark £500 million national effort, Sovereign AI, designed to transform Britain into a global leader in artificial intelligence by backing its most promising homegrown startups. Latest Content Veeva Announces Falcon, an Agentic Platform and Standard Agents to Deliver Agentic Labor in Drug Development Jagat Adhiya Google launches $10m quantum AI programme for life sciences New technologies Solution Accelerators for biotech research Merz consolidates its R&D with a Life Sciences platform White papers Centralising analytical data from mass spectrometry in drug discovery and development Discover how experts from Zoetis, Bayer, LifeMine Therapeutics, Iterion, Targenomix, and the Pistoia Alliance are solving key data challenges for mass spectrometry applications. Standardization of Analytical Data: Best Practices Standardization is critical to extracting the full potential of data. This White Paper offers a comprehensive guide to overcoming challenges and driving progress in analytical chemistry and beyond. Advancing the use of emerging computing infrastructure in Life Sciences RCH Solutions supports the adoption of novel computing technologies such as cloud, quantum, AI and edge computing paradigms through a co Webcasts On Demand Webinar: Consolidating computing resources can democratise research infrastructure More content Machine learning algorithm brings long-read sequencing to the clinic Dassault Systèmes launch nationwide Health Data Warehouse in France Two QuEra contributions move to phase three of Wellcome Leap's Quantum for Bio Challenge The latest solutions for automation and AI in lab software in 2025 Veeva Systems launches a new initiative to help life sciences companies automate tasks Sapio Sciences introduces biorepository management US NSF director steps down Sign up now for our next roundtable on analytical data challenges in pharma Revvity fuels the future of cancer science with research solutions eXoZymes creates AI-engineered enzymes for biomanufacturing Life science professionals say agentic AI will have greatest impact in next 2-3 years Phasecraft develops algorithm to improve quantum simulation efficiency Pagination Previous page ‹ Previous Page 6 Next page Next ›
